Home
E-Submission
Sitemap
Contact Us
ABOUT
Aims and scope
About the journal
Editorial board
Best practice
Open access
Contact us
BROWSE ARTICLES
All issues
Current issue
Most read articles
Most download articles
Most cited articles
Search
Author index
EDITORIAL POLICY
Research and publication ethics
Advertising policy
FOR CONTRIBUTORS
Instructions for authors
Author’s checklist
Copyright transfer agreement
Article processing charge
Readership
E-submission
Search
Current issue
Page Path
HOME
BROWSE ARTICLES
Current issue
Volume 16(1); Jun 2025
Review Articles
신경학적 면역관문억제제 연관 부작용의 진단과 치료
현재원
J Mult Scler Neuroimmunol.
2025;16(1):1-7. Published online June 30, 2025
DOI:
https://doi.org/10.59578/jmsni.2025.16.1.1-7
PDF
희귀 신경계질환 극복을 위한 전문가 단체와 환자 단체와의 협력
김기훈, 권영남, 김준순, 김수영, 김승우, 박기홍, 박진성, 봉정빈, 석진명, 석흥열, 이혜림, 조은빈, 전병준, 오성일, 대한신경면역학회 홍보위원회
J Mult Scler Neuroimmunol.
2025;16(1):8-18. Published online June 30, 2025
DOI:
https://doi.org/10.59578/jmsni.2025.16.1.8-18
PDF
Original Article
Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France
Grégoire Mercier, David Pau, Guillaume Bourel, Manon Belhassen, Floriane Deygas, Clarisse Marchal, Sophie Larrieu, Alexandre Civet, Xavier Moisset
J Mult Scler Neuroimmunol.
2025;16(1):19-25. Published online June 30, 2025
DOI:
https://doi.org/10.59578/jmsni.2025.16.1.19-25
PDF
Case Report
GM1, GD1a 항체 양성인 횡단성척수염과 병발한 급성운동축삭신경병의 임상적 증상과 예후
김아영, 유홍근, 전종현, 권혁성
J Mult Scler Neuroimmunol.
2025;16(1):26-32. Published online June 30, 2025
DOI:
https://doi.org/10.59578/jmsni.2025.16.1.26-32
PDF
Letter to the Editor
낮은 역가 MOG항체 양성 소견의 신중한 해석과 감별 진단의 중요성
현재원, 김호진
J Mult Scler Neuroimmunol.
2025;16(1):33-34. Published online June 30, 2025
DOI:
https://doi.org/10.59578/jmsni.2025.16.1.33-34
PDF
Journal of Multiple
Sclerosis and
Neuroimmunology
Print ISSN: 2733-8290
Online ISSN: 2951-2972
MOST VIEWED
MOST CITED
7,558
Understanding MRI Features of Multiple Sclerosis: Based on the 2017 McDonald Criteria
4,086
Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
3,684
National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
3,561
Rituximab Treatment for Neuroimmunologic Disorders
2,917
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
+more
Cited By
4
Multiple Sclerosis in Korea: A Hospital-Based, Multicenter, Epidemiological Study
Cited By
1
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Review
Cited By
1
National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Cited By
1
A Case of Post-Infective Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease
+more